Your browser doesn't support javascript.
loading
Nutritional intervention in the management of non-alcoholic fatty liver disease.
Brunetto, Maurizia R; Salvati, Antonio; Petralli, Giovanni; Bonino, Ferruccio.
Afiliación
  • Brunetto MR; Hepatology Unit, Reference Centre of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Via Paradisa 2, 56124, Pisa, Italy; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; Institute of Biostructure and Bioimaging, National Researc
  • Salvati A; Hepatology Unit, Reference Centre of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Via Paradisa 2, 56124, Pisa, Italy. Electronic address: a.salvati@ao-pisa.toscana.it.
  • Petralli G; Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Italy. Electronic address: g.petralli94@gmail.com.
  • Bonino F; Hepatology Unit, Reference Centre of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Via Paradisa 2, 56124, Pisa, Italy; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Electronic address: ferruccio.bonino@libero.it.
Article en En | MEDLINE | ID: mdl-37094914
ABSTRACT
Lifestyle modification is the primary intervention to control NAFLD progression, but despite evidence-based effectiveness it is difficult to distinguish the benefits of nutrition from physical activity and the optimal diet composition is not established. Macronutrients as saturated fatty acids, sugars and animal proteins are harmful in NAFLD and the Mediterranean Diet reducing sugar, red meat and refined carbohydrates and increasing unsaturated-fatty-acids was reported to be beneficial. However one size cannot fit all since NAFLD is a multifaceted syndrome encompassing many diseases of unknown etiologies, different clinical severity and outcomes. Studies of the intestinal metagenome, provided new insights into the physio-pathological interplay between intestinal microbiota and NAFLD. How much the microbiota heterogeneity can influence response to diet remains unknown. New knowledge indicates that AI guided personalized nutrition based on clinic-pathologic and genetic data combined with pre/post nutritional intervention gut metagenomics/metabolomics will be part of the future management of NAFLD.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Microbiota / Enfermedad del Hígado Graso no Alcohólico Límite: Animals / Humans Idioma: En Revista: Best Pract Res Clin Gastroenterol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Microbiota / Enfermedad del Hígado Graso no Alcohólico Límite: Animals / Humans Idioma: En Revista: Best Pract Res Clin Gastroenterol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article